Drug-resistant TB: latest news

Drug-resistant TB resources

Drug-resistant TB features

Drug-resistant TB news from aidsmap

More news

Drug-resistant TB news selected from other sources

  • Bulk of world’s MDR-TB cases undiagnosed – WHO

    The world may be losing the war against the rise of drug-resistant tuberculosis (TB) as the bulk of patients with multidrug-resistant TB go undiagnosed, according to the World Health Organisation’s (WHO) latest TB report.

    28 October 2015 | Health-E News
  • Nonprofit Gets Back Drug and Reverses 18-Fold Increase in Price

    A nonprofit in Indiana has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90% after re-acquiring rights to the medicine from Rodelis Therapeutics, the latest sign of a growing outcry over skyrocketing costs for rare disease treatments.

    22 September 2015 | Bloomberg
  • NHS England commissions first new TB drugs in 50 years

    NHS England has published a new Clinical Commissioning Policy making Janssen’s Sirturo and Otsuka’s Deltyba routinely available on the National Health Service for the treatment of pulmonary multi-drug resistant tuberculosis, offering patients easier access to the first novel therapies in nearly 50 years.

    25 August 2015 | Pharma Times
  • Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

    The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

    04 August 2015 | Intellectual Property Watch
  • Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment

    The United States plans to place 360,000 multidrug-resistant tuberculosis patients globally on treatment over the next five years, as part of a national tuberculosis action plan currently under draft.

    27 July 2015 | Science Speaks
  • The Medicines Patent Pool Releases Independent Feasibility Studies on Hepatitis C and Tuberculosis

    As part of its ongoing consultation processes on the possibility of the Medicines Patent Pool (MPP) expanding into other disease areas, the organisation has published independent feasibility studies exploring the case for potential entry into Hepatitis C and Tuberculosis.

    07 July 2015 | Medicines Patent Pool
  • Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB

    Some strains of multidrug-resistant tuberculosis (MDRTB) may have a lower fitness (be less capable of spreading) than drug-susceptible tuberculosis bacteria, according to a study published this week in PLOS Medicine.

    24 June 2015 | Eurekalert Inf Dis
  • Large-scale study underscores value of routine Xpert testing on TB, MDR TB case finding

    A study of more than 100,000 patients with suspected tuberculosis at 18 sites across India showed that routine testing using Xpert molecular technology rather than the most commonly used — and oldest — diagnostic tool of examining a sputum smear under a microscope, increased detection of TB by 39 percent and led to five times the rate of detecting resistance to a TB treatment medicine.

    28 May 2015 | Science Speaks
  • First all-oral XDR-TB drug regimen trial launches in South Africa

    The regimen is comprised of bedaquiline, which received provisional approval from the U.S. Food and Drug Administration in 2013 to treat drug-resistant tuberculosis, pretomanid a new type of antibacterial drug, and linezolid which is used off-label to treat TB.

    15 May 2015 | Science Speaks
  • WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

    WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia) and multi-drug resistant tuberculosis (TB), among others.

    11 May 2015 | World Health Organization
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also